⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
DFTX News
Definium Therapeutics, Inc. Common Shares
Definium Therapeutics, Inc. Announces Pricing of $700 Million Upsized Public Offering
businesswire.com
DFTX
Definium Therapeutics, Inc. Announces Proposed Public Offering
businesswire.com
DFTX
Form 8-K
sec.gov
DFTX
Definium Therapeutics Announces New Employee Inducement Grants
businesswire.com
DFTX
Form 8-K
sec.gov
DFTX
Definium Therapeutics Announces New Employee Inducement Grants
businesswire.com
DFTX
Definium Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference
businesswire.com
DFTX
Form 8-K
sec.gov
DFTX
Form 8-K
sec.gov
DFTX
Definium Therapeutics Announces First Patient Dosed in Ascend, the Second Phase 3 Pivotal Study of DT120 ODT in Major Depressive Disorder
businesswire.com
DFTX